Arch Biopartners Says University Health Network Joining Phase II Trial of LSALT Peptide
Arch Biopartners Says University Health Network Joining Phase II Trial of LSALT Peptide
Arch Biopartners称大学健康网络正在加入LSALT肽的二期试验
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间